NANCY HOFFMAN: Open Payments
NPI 1003864018 · NEW RICHMOND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 50 payments from 18 companies in 2025. Trend: 2023 $1,089 · 2024 $1,525 · 2025 $854
Food & beverage: $831Education: $23
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $148 |
| Lilly USA, LLC | 9 | $129 |
| Novo Nordisk Inc | 6 | $118 |
| PFIZER INC. | 3 | $64 |
| Amgen Inc. | 3 | $59 |
| Supernus Pharmaceuticals, Inc. | 3 | $55 |
| Exact Sciences Corporation | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $26 |
Products named: VRAYLAR, MOUNJARO, OTEZLA, JARDIANCE, UBRELVY, Ozempic, ELIQUIS, CAPLYTA.
Industry payments across OH — which companies pay providers there.
